Welcome to Markets Desk, here's what's moving the needle right now.
Alphabet steps into the earnings spotlight Wednesday, and the question hanging over the report is simple: is all that capital expenditure on data centers actually translating into revenue? Investors want proof that AI monetization is real, not just a line item on a balance sheet. The stakes are high.
Shifting to pharma, Novo Nordisk has filed suit against Eli Lilly, alleging that Lilly's advertising around its GLP-one medications relies on outdated clinical data and amounts to false advertising under federal and state law, including the Lanham Act. This is a direct legal confrontation between two of the biggest names in the obesity and diabetes drug space, and it will be watched closely for what it signals about competitive conduct in a market growing faster than either company can fully capture.
Meanwhile, in the prediction markets space, Kalshi's experience with the World Cup is drawing real attention. The company badly underestimated organic demand when the tournament opened on American soil, with signups and trading volume surging well beyond projections. Their read is that AI-driven content aggregation may actually be rebuilding the kind of shared cultural moment that fragmentation had nearly destroyed.
That's the tape. Markets Desk, signing off the floor.
